Status:
WITHDRAWN
Evaluating Endometriosis With 16α-(18)F-fluoro-17β-estradiol ([F-18] FES) PET/MRI
Lead Sponsor:
Annie (Annie) T. Packard
Conditions:
Endometriosis
Eligibility:
FEMALE
18-50 years
Phase:
PHASE1
PHASE2
Brief Summary
Researchers are trying to improve the detection of endometriosis using F-18 FES PET/MRI imaging.
Eligibility Criteria
Inclusion
- \- Premenopausal women (18-50) with endometriosis
Exclusion
- Postmenopausal women
- AP diameter when lying supine greater than 32 cm (too large for PET/MRI)
- Unable to undergo PET/MRI for any reason (metal implants, severe claustrophobia)
- Unable to receive IV Gadolinium contrast for any reason (renal failure eGFR \< 60, contrast allergy)
- Pregnant (Urine test will be provided for all patients)
Key Trial Info
Start Date :
October 7 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2024
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04347135
Start Date
October 7 2022
End Date
April 30 2024
Last Update
May 10 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905